Insights Into Thyroid Cancer 2023

Perspectives on drivers in treatment pathways for thyroid cancer

East – April 3, 2023
Purchase Report

Faculty Chair

Lori Wirth, MD

Massachusetts General Hospital, Boston, USA

West – May 9, 2023
Purchase Report

Faculty Chair

Lori Wirth, MD

Massachusetts General Hospital, Boston, USA

More Information

  • Virtual series
  • East Coast

More Information

  • Virtual series
  • West Coast

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of thyroid cancer
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Management of radioiodine (RAI)-refractory or -ineligible metastatic differentiated thyroid cancer (mDTC)
    • Second-line systemic therapy

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and in-depth moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.